Stay updated on Nivolumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check27 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has undergone significant content changes regarding a clinical study on Multiple Myeloma, including the removal of detailed study descriptions and inclusion/exclusion criteria, while adding a new revision number and collaborators.SummaryDifference5%
Stay in the know with updates to Nivolumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.